LMAT
Price
$84.19
Change
-$0.47 (-0.56%)
Updated
Sep 26 closing price
Capitalization
1.91B
32 days until earnings call
PDEX
Price
$33.99
Change
+$0.34 (+1.01%)
Updated
Sep 26 closing price
Capitalization
110.87M
32 days until earnings call
Interact to see
Advertisement

LMAT vs PDEX

Header iconLMAT vs PDEX Comparison
Open Charts LMAT vs PDEXBanner chart's image
LeMaitre Vascular
Price$84.19
Change-$0.47 (-0.56%)
Volume$169.9K
Capitalization1.91B
Pro-Dex
Price$33.99
Change+$0.34 (+1.01%)
Volume$22.07K
Capitalization110.87M
LMAT vs PDEX Comparison Chart in %
Loading...
LMAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PDEX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LMAT vs. PDEX commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMAT is a Buy and PDEX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (LMAT: $84.19 vs. PDEX: $33.99)
Brand notoriety: LMAT and PDEX are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: LMAT: 91% vs. PDEX: 54%
Market capitalization -- LMAT: $1.91B vs. PDEX: $110.87M
LMAT [@Pharmaceuticals: Other] is valued at $1.91B. PDEX’s [@Pharmaceuticals: Other] market capitalization is $110.87M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $158.13B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LMAT’s FA Score shows that 1 FA rating(s) are green whilePDEX’s FA Score has 0 green FA rating(s).

  • LMAT’s FA Score: 1 green, 4 red.
  • PDEX’s FA Score: 0 green, 5 red.
According to our system of comparison, LMAT is a better buy in the long-term than PDEX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LMAT’s TA Score shows that 5 TA indicator(s) are bullish while PDEX’s TA Score has 6 bullish TA indicator(s).

  • LMAT’s TA Score: 5 bullish, 6 bearish.
  • PDEX’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, PDEX is a better buy in the short-term than LMAT.

Price Growth

LMAT (@Pharmaceuticals: Other) experienced а -8.74% price change this week, while PDEX (@Pharmaceuticals: Other) price change was -1.08% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.13%. For the same industry, the average monthly price growth was -3.06%, and the average quarterly price growth was +8.48%.

Reported Earning Dates

LMAT is expected to report earnings on Oct 30, 2025.

PDEX is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LMAT($1.91B) has a higher market cap than PDEX($111M). LMAT has higher P/E ratio than PDEX: LMAT (41.07) vs PDEX (12.73). LMAT YTD gains are higher at: -7.992 vs. PDEX (-27.294). LMAT has higher annual earnings (EBITDA): 73.8M vs. PDEX (14.1M). LMAT has more cash in the bank: 319M vs. PDEX (7.16M). PDEX has less debt than LMAT: PDEX (16.6M) vs LMAT (186M). LMAT has higher revenues than PDEX: LMAT (235M) vs PDEX (66.6M).
LMATPDEXLMAT / PDEX
Capitalization1.91B111M1,717%
EBITDA73.8M14.1M523%
Gain YTD-7.992-27.29429%
P/E Ratio41.0712.73323%
Revenue235M66.6M353%
Total Cash319M7.16M4,456%
Total Debt186M16.6M1,120%
FUNDAMENTALS RATINGS
LMAT vs PDEX: Fundamental Ratings
LMAT
PDEX
OUTLOOK RATING
1..100
6154
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
65
Fair valued
PROFIT vs RISK RATING
1..100
2680
SMR RATING
1..100
5736
PRICE GROWTH RATING
1..100
6265
P/E GROWTH RATING
1..100
7798
SEASONALITY SCORE
1..100
1645

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LMAT's Valuation (55) in the Medical Specialties industry is in the same range as PDEX (65) in the Medical Or Nursing Services industry. This means that LMAT’s stock grew similarly to PDEX’s over the last 12 months.

LMAT's Profit vs Risk Rating (26) in the Medical Specialties industry is somewhat better than the same rating for PDEX (80) in the Medical Or Nursing Services industry. This means that LMAT’s stock grew somewhat faster than PDEX’s over the last 12 months.

PDEX's SMR Rating (36) in the Medical Or Nursing Services industry is in the same range as LMAT (57) in the Medical Specialties industry. This means that PDEX’s stock grew similarly to LMAT’s over the last 12 months.

LMAT's Price Growth Rating (62) in the Medical Specialties industry is in the same range as PDEX (65) in the Medical Or Nursing Services industry. This means that LMAT’s stock grew similarly to PDEX’s over the last 12 months.

LMAT's P/E Growth Rating (77) in the Medical Specialties industry is in the same range as PDEX (98) in the Medical Or Nursing Services industry. This means that LMAT’s stock grew similarly to PDEX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LMATPDEX
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bearish Trend 3 days ago
48%
Bullish Trend 3 days ago
75%
MACD
ODDS (%)
Bearish Trend 3 days ago
52%
Bullish Trend 3 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
57%
Bearish Trend 3 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
52%
Bearish Trend 3 days ago
73%
Advances
ODDS (%)
Bullish Trend 13 days ago
73%
Bullish Trend about 1 month ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
53%
Bearish Trend 6 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
74%
Aroon
ODDS (%)
Bearish Trend 3 days ago
62%
Bearish Trend 3 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
LMAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PDEX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRDSF5.650.21
+3.93%
Prada Spa
AATC6.640.01
+0.21%
Autoscope Technologies Corporation
DCNNF0.03N/A
N/A
QUEST CRITICAL METALS INC.
BJWTF0.31N/A
N/A
Beijing Enterprises Water Group, Ltd.
NXFNF3.65N/A
N/A
NEXT 15 GROUP PLC

LMAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, LMAT has been loosely correlated with ITGR. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if LMAT jumps, then ITGR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LMAT
1D Price
Change %
LMAT100%
-0.56%
ITGR - LMAT
47%
Loosely correlated
-0.27%
SYK - LMAT
47%
Loosely correlated
+0.12%
UFPT - LMAT
45%
Loosely correlated
+1.84%
AORT - LMAT
41%
Loosely correlated
+1.56%
SOLV - LMAT
40%
Loosely correlated
+1.29%
More

PDEX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PDEX has been loosely correlated with LMAT. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PDEX jumps, then LMAT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDEX
1D Price
Change %
PDEX100%
+1.01%
LMAT - PDEX
38%
Loosely correlated
-0.56%
LDXHF - PDEX
26%
Poorly correlated
N/A
TCMD - PDEX
25%
Poorly correlated
+1.70%
WAT - PDEX
23%
Poorly correlated
+1.36%
ESTA - PDEX
23%
Poorly correlated
N/A
More